← Back to scans

Will Altria Group Inc. report Above 54.5 billion domestic cigarette shipments in 2026?

KXMOA-28JANCIGS-54500000000.0 · Companies · 2026-08-29
92%
Agent
89%
Market Price
+3.0%
Edge
75%
Confidence
Volume: 12,011
Spread: 8.0c
Days to resolution: 579
Markets in event: 14
Final Rationale
The 2025 exit base of ~61.7B sticks means FY2026 must decline ~11.7% to breach 54.5B, worse than any recent full-year rate (~10% plateau for three years). H1 2026 actuals point strongly the other way — Q1 beat on volume and Q2 fell only 3.2% YoY — so with roughly half the year already banked at a ~3-8% decline pace, H2 would need to deteriorate to ~18-20% declines for No, a magnitude never observed. The critique's points are fair but mostly directional noise: trade-inventory timing effects and possible renewed illicit-vape enforcement create real H2 tail risk, and the implied (not directly sourced) 61.7B base adds modest calculation uncertainty; these justify not going far above the market. The pre-2026-trend-only Monte Carlo (35-50%) is properly discounted because it ignores the decisive primary H1 2026 data, and Kalshi's 6pt drift down likely reflects liquidity/thin-market noise rather than material new information. I settle marginally above the 89% anchor at 92%.
Price vs. prediction
How the market moved after the agent's call. Solid blue line is the actual market price; dashed line is the agent's static forecast at $t{=}0$.
$n = 4$ follow-ups
Re-scan Context
This market has been scanned before. Previous predictions:
DatePredictedMarket PriceConfidence
2026-08-22 88% 89% 62%
2026-07-01 80% 93% 50%
1. Planner Opus · Fermi decomposition + tool plan
Tools chosen: kalshi_direct kalshi_related claude_news gdelt_news earnings_data code_execution wikipedia
Sub-questions (Fermi decomposition)
  1. What were Altria's reported domestic cigarette shipment volumes for 2021, 2022, 2023, 2024 and full-year 2025 (or YTD 2025)?
  2. What is the year-over-year percentage decline rate in each of the last 4 years, and is it accelerating or decelerating?
  3. Do Altria's quarterly 2025 shipment declines (Q1-Q4) suggest a run-rate above or below a 10% annual decline heading into 2026?
  4. How much do trade-inventory movements, the illicit flavored-vape crackdown, and NJOY/on! substitution affect reported shipment volumes vs. retail share?
  5. What is the Kalshi price ladder across the other KXMOA-28JANCIGS thresholds, implying a distribution for 2026 shipments?
  6. Does Altria give volume guidance or do analysts publish 2026 cigarette volume forecasts near 54-56 billion sticks?
Planner reasoning
This is a near-threshold extrapolation question: Altria's domestic cigarette shipment volume has been declining ~9-11%/yr, and 54.5B for 2026 sits close to a straight extrapolation from 2025. Key research is exact reported shipment volumes for 2022-2025 (including quarterly 2025 trends), the decline rate trajectory, and the Kalshi market's own ladder of thresholds which reveals the implied distribution.
2. Research Parallel tool calls
ToolStatusTimeItemsSummary
kalshi_direct OK 0.2s 1 ## This Market's Kalshi Data **Above 54.5 billion** (KXMOA-28JANCIGS-54500000000.0) - Current price (probability): 89.00% - 7-day price change: -1.00% - 30-day price change: -6.00% - Average daily volume: 858 contracts - Price range: 86.00% - 98.00% - Data points: 14 days
kalshi_related OK 1.9s 2 2 related markets / summaries. series KXMOA: 0 markets (skipped 14 no-signal) | keyword 'Altria cigarette shipments': ok | keyword 'domestic cigarette shipments': ok
claude_news OK 33.3s 13 Here are the key findings on Altria's domestic cigarette shipment volumes and 2026 outlook: **Historical annual volumes & YoY declines:** - **2021:** Reported domestic cigarette shipment volume declined **7.5%** for the full year volume dropping 7.5% in 2021, 9.7% in 2022, 9.9% in 2023, and 10.2%
gdelt_news OK 85.1s 10 GDELT: 10 articles across 3 queries (lookback=180d). 'Altria cigarette shipment volume decline': 10 hits | 'Altria fourth quarter 2025 earnings cigarette volume': error HTTPSConnectionPool(host='api.gdeltproject.org', port=443): Max retries exceeded with url: /api/v2/doc/doc?query=%28altria+OR+fourt
earnings_data OK 2.1s 1 Fetched FMP data for 1 ticker(s).
code_execution OK 34.2s 0 ## Key Findings - **Historical decline rates (2021→2025):** 7.83% (21→22), 10.71% (22→23), 11.99% (23→24), 10.37% (24→25). Average ≈ **10.2%**, with the most recent year (10.37%) close to the average — suggesting no strong acceleration/deceleration trend, though 2023-24 saw the steepest drop. - **
wikipedia OK 1.9s 1 Fetched 1 Wikipedia entries (0 missing pages).
3. Evidence Brief Sonnet · 5950 chars
# Current state Altria has already reported Q1 and Q2 2026 actual results (as of the research cutoff, ~Aug 2026). Q2 2026 domestic cigarette shipment volume fell just 3.2% YoY — a sharp deceleration from the ~10-14% quarterly declines seen throughout 2024-2025 — and Q1 2026 beat expectations on stronger-than-expected cigarette volumes. Full-year 2026 results (needed for resolution) are not yet final, but the resolving base (2025 full-year volume, down 10.0% to ~61.7B sticks) plus H1 2026 deceleration strongly favor clearing the 54.5B threshold. # Timeline of key events - 2024 FY (reported early 2025): domestic shipment volume declined 10.2%, ending 2024 at ~68.6B sticks (confirmed, 10-K/SEC). - 2025-Q1: volume down 13.7% (confirmed, 8-K). - 2025-Q2: volume down 11.9% (confirmed, Altria IR release). - 2025-Q3: volume down 8.2%; nine-months down 10.6% (confirmed, Altria IR release). - 2025 FY (reported ~Jan/Feb 2026): full-year volume down 10.0%, implying ~61.7B sticks entering 2026 (confirmed, FY2025 10-K). - 2026-04-29: Q1 2026 results — earnings/volume beat, guidance reaffirmed, management cites moderated cross-category movement to e-vapor (confirmed, Morningstar/Altria release). - 2026-07-29/30: Q2 2026 results — domestic cigarette shipment volume down only 3.2% YoY; smokeable revenue and adjusted OCI grew despite volume decline (confirmed, 8-K/StockTitan); stock nonetheless sold off same day for unrelated reasons (reported, Motley Fool/Yahoo, cause not tied to cigarette volume in retrieved text). # Event Will Altria report full-year 2026 domestic cigarette shipments Above 54.5 billion sticks? # Outcomes to forecast Yes / No (single threshold; Yes = >54.5B sticks reported for FY2026) # Kalshi market anchor Current YES price: **89%**. 7-day change: -1pt; 30-day change: -6pt (drifted down from high of 98% to range 86-98%). Average daily volume: 858 contracts — moderate liquidity. Market is pricing this as highly likely to resolve Yes. # Sub-question answers 1. **Historical volumes 2021-2025**: 2024 ended at ~68.6B sticks (confirmed, 10-K). 2025 full-year declined 10.0%, implying ~61.7B sticks (calc. from confirmed % + 2024 base). Absolute 2021-2023 figures not directly given but declines were 7.5% (2021), 9.7% (2022), 9.9% (2023). 2. **YoY decline trend**: 7.5%→9.7%→9.9%→10.2%→10.0% (2021-2025), roughly flat/plateauing near 10% the last three years — not accelerating (claude_news, Altria press releases). 3. **2025 quarterly run-rate**: Q1 -13.7%, Q2 -11.9%, Q3 -8.2%, FY -10.0% — decelerating through the year, ending essentially at the historical ~10% average, not above it. 4. **Trade inventory/vape crackdown/NJOY-on! substitution**: Altria's own disclosures attribute declines primarily to "industry decline rate (impacted by illicit e-vapor growth)," retail share losses, and trade inventory swings; Q3 2025 decline was partly offset by favorable trade inventory movements (confirmed, Altria IR). Q1/Q2 2026 management explicitly cites "moderated cross-category movement to e-vapor" as improving cigarette volume trends (confirmed). 5. **Kalshi price ladder**: Only the 54.5B threshold market data was retrieved; no adjacent KXMOA thresholds found (kalshi_related returned no other KXMOA tickers, only unrelated Constellation/Ferrari markets) — no distribution ladder available. 6. **Guidance/analyst forecasts**: No explicit 2026 volume-in-sticks guidance found; Altria's 2026 guidance references "moderated e-vapor industry growth" and larger H2 import/export benefit, consistent with volume stabilization (claude_news). No third-party analyst point estimate (54-56B) was located in research. # Key facts (high-confidence, factual) 1. [Altria 10-K/IR] FY2024 volume declined 10.2%, ending near 68.6B sticks. 2. [Altria 10-K/IR] FY2025 volume declined 10.0% (~61.7B sticks implied). 3. [8-K, StockTitan] Q2 2026 volume declined only 3.2% YoY. 4. [Morningstar/Altria] Q1 2026 beat expectations; guidance reaffirmed. 5. [Kalshi] Current YES price 89%, trending down slightly over 30 days. # Cross-market signals - Kalshi related: No other KXMOA-28JANCIGS threshold tickers found (likely low liquidity/no-signal); no arbitrage ladder visible. - Polymarket: not covered in research. - Sportsbook implied: N/A (not a sports event). # Analyst opinions and speculation - Financial media (Fool, Yahoo, InsiderMonkey) frame Altria mid-2026 as resilient on dividend/EPS grounds despite volume erosion, but do not give explicit stick-count forecasts. - code_execution's independent Monte Carlo (using only pre-2026 historical decline trend, ~10.2% avg) estimated P(Yes)≈35-50%, materially below Kalshi's 89% — but this model did not incorporate actual Q1/Q2 2026 deceleration data, which is the more decisive, primary evidence. # Directional lean per outcome - **Yes (>54.5B)**: Strongly supported — 2025 base (~61.7B) requires an 11.7%+ full-year decline to breach the threshold, above the recent 10% trend; H1 2026 actuals show sharp deceleration (Q1 beat, Q2 -3.2%), making breach unlikely. Kalshi (89%) and structural math align. - **No (≤54.5B)**: Would require decline to reaccelerate sharply in H2 2026 versus H1's ~3-8% trend — no evidence found supporting this; historical worst-case was 13.7% (Q1 2025), but full-year rates have stayed near 10%. # Gaps / unknowns - No confirmed Q3/Q4 2026 data (year not complete); H2 trajectory could shift with e-vapor enforcement changes. - Absolute 2021-2023 stick counts not directly sourced (only % declines). - No adjacent Kalshi threshold prices to build implied distribution. - No explicit analyst point forecasts near 54-56B found. # Calibration anchors - Kalshi current YES price: 89% (primary anchor). - Breakeven decline rate to hit exactly 54.5B from ~61.7B 2025 base: ~11.7%, above the trailing 3-year average (~10%) and well above H1 2026 actual (~3-8%) — supports Yes being priced correctly near current market level, possibly even higher.
4. Forecasters Opus + GPT · in parallel
claude-opus-5
0.72
Yes 92%
No 8%
Altria ended 2025 at ~61.7B sticks (FY2025 -10.0% off a ~68.6B 2024 base), so breaching 54.5B requires a full-year 2026 decline of ~11.7%, worse than any recent full-year rate. H1 2026 actuals point the other way: Q1 beat with stronger-than-expected volumes and Q2 declined only 3.2% YoY, with management citing moderated cross-category movement to e-vapor — a sharp deceleration from the 8-14% quarterly declines of 2024-25. For No to resolve, H2 declines would have to reaccelerate to ~18-20%, for which no evidence exists. Kalshi anchors at 89%; the primary H1 data argues the true probability is modestly higher, though residual uncertainty on the exact 2025 stick base and unreported H2 trends keeps me short of extreme confidence.
gpt-5.6-sol
0.78
Yes 92%
No 8%
The 2025 base of about 61.7B means shipments can decline roughly 11.7% in 2026 and still remain near the 54.5B threshold, while annual declines have plateaued around 10% rather than accelerating. The 2025 quarterly pattern was already improving, and Q1 2026 beat expectations followed by only a 3.2% YoY decline in Q2, pointing toward Yes because H2 would need an unusually sharp deterioration to produce No. Management's comments about moderated migration to illicit e-vapor and reaffirmed guidance also support stabilization, although absent Q3 and Q4 results leave some tail risk from inventory swings or renewed category pressure. I therefore move modestly above the 89% Kalshi YES anchor to 92%.
5. Devil's Advocate Sonnet · red-team critique
1. Both forecasters converge on 92% with near-identical reasoning, but neither engages with the code_execution Monte Carlo model that flagged P(Yes)≈35-50% using pre-2026 trend data alone — even though this model is discounted for lacking H1 2026 data, its wide divergence from Kalshi should prompt more explicit discussion of why the historical-trend-only view is wrong rather than simply dismissing it. 2. Neither forecast weights the "trade inventory" caveat sufficiently: the brief notes Q3 2025's deceleration was "partly offset by favorable trade inventory movements," meaning Q1/Q2 2026's improvement could partly reflect similar timing/channel-stuffing effects rather than true underlying demand stabilization, which could reverse in H2 and isn't addressed by either rationale. 3. Both treat the 61.7B 2025 base as solid, but the brief explicitly flags this figure as "implied" (calculated from confirmed % decline, not a directly confirmed absolute stick count) — neither forecaster acknowledges this calculation uncertainty as a source of threshold-breach risk in either direction. 4. Neither model addresses why Kalshi's price has drifted down 6pts over 30 days (from a high of 98% to 86-98% range) despite H1 data supporting Yes — this recent softening could reflect information forecasters are missing (e.g., early H2 signals, regulatory/illicit vape enforcement changes) and deserves at least a brief hypothesis rather than being ignored. 5. Both forecasts push above the Kalshi anchor to 92% citing "primary H1 data," but neither quantifies how much of FY2026's shipment total is already locked in by H1 actuals versus how much uncertainty remains in unreported H2 — given H1 is roughly half the year, the confident 92% may not adequately reflect the real variance in H2 outcomes (e.g., illicit vape enforcement reversal, competitive share loss) that could still swing the full-year decline rate closer to the 11.7% breakeven. 6. Neither forecaster explores the tail scenario where e-vapor enforcement actions (e.g., FDA crackdowns) that drove 2024-2025 declines could resume or intensify in H2 2026, which is the single most-cited causal driver in the brief ("illicit e-vapor growth") and represents the primary risk to the Yes thesis that goes unmodeled.
6. Aggregator Opus · final calibrated forecast
92% (75% confidence)
Yes: 92% No: 8%
The 2025 exit base of ~61.7B sticks means FY2026 must decline ~11.7% to breach 54.5B, worse than any recent full-year rate (~10% plateau for three years). H1 2026 actuals point strongly the other way — Q1 beat on volume and Q2 fell only 3.2% YoY — so with roughly half the year already banked at a ~3-8% decline pace, H2 would need to deteriorate to ~18-20% declines for No, a magnitude never observed. The critique's points are fair but mostly directional noise: trade-inventory timing effects and possible renewed illicit-vape enforcement create real H2 tail risk, and the implied (not directly sourced) 61.7B base adds modest calculation uncertainty; these justify not going far above the market. The pre-2026-trend-only Monte Carlo (35-50%) is properly discounted because it ignores the decisive primary H1 2026 data, and Kalshi's 6pt drift down likely reflects liquidity/thin-market noise rather than material new information. I settle marginally above the 89% anchor at 92%.
Pipeline Timing
Total pipeline time: 181.3s
Per-tool research timings shown in the Research section above.